Celldex Therapeutics, Inc. (CLDX)
32.24
-1.38
(-4.10%)
USD |
NASDAQ |
Apr 10, 16:00
32.27
+0.03
(+0.09%)
After-Hours: 20:00
Celldex Therapeutics Free Cash Flow : -213.66M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Plus Therapeutics, Inc. | -20.84M |
| Atossa Therapeutics, Inc. | -29.78M |
| Abeona Therapeutics, Inc. | -84.30M |
| Cell Source, Inc. | -- |
| Kiora Pharmaceuticals, Inc. | -10.07M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -63.94M |
| Cash from Investing (Quarterly) | 55.42M |
| Cash from Financing (Quarterly) | 1.349M |
| Free Cash Flow Per Share (Quarterly) | -0.9809 |
| Free Cash Flow to Equity (Quarterly) | -64.94M |
| Free Cash Flow to Firm (Quarterly) | -65.22M |
| Free Cash Flow Yield | -9.98% |